Sensei Biotherapeutics Company

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Technology: Viral Vectors
Industry: Viral Vectors
Headquarters: Gaithersburg, Maryland, United States
Founded Date: 1999-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 10
Total Funding: 58500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-01-11
Last Funding Type: Series B

Visit Website
Register and Claim Ownership